/Investor DB

Maverick Ventures — 2017 Investments

8 investments dated 2017 · listed companies and verified rows first · show all

Seerseer.bioinNASDAQ: SEERDec 2017

Seer develops proteomics tools for large-scale protein analysis, including an assay, automation instrument, and analysis software for studying the proteome across human and non-human samples.

BiotechDeep TechHardwareHealthtechBoston, US

Omid Farokhzad(Founder)inPhilip Ma(Executive Officer)Shadi Aryanpour(Executive Officer)David Singer(Director)Omid Cameron Farokhzad(Founder)in

BoardTerrance McGuire(Director)

Co-investorsSoftBank Vision FundSolasta VenturesWingaMoonPolaris PartnersT. Rowe Price

1Mg1mg.comJul 2017Acquired

This is a product listing page on an online pharmacy for Tugain Twins 5 Solution, a topical minoxidil-based medicine sold to treat hair loss and promote hair regrowth.

Digital HealthE-commerceHealthtechIndia, IN

Gaurav Agarwal(Founder)Prashant Tandon(Founder)Vikas Chauhan(Founder)

Co-investorsHBM Healthcare InvestmentsHBM PartnersKae CapitalLeo Capital VenturesPeak XV PartnersSpring Marketing Capital+3 more

Adentroadentro.cominMar 2017

Adentro is a physical identity and measurement platform that uses a business's existing guest WiFi access points to turn anonymous foot traffic into customer profiles, power automated win-back marketing, and measure which ads drove in-store visits via its Walk-Through Rate metric.

AdTechData & InfrastructureMarketing TechRetail TechSaaSSan Francisco, US

Jack Abraham(Co-founder; CEO 2012–2018, then Executive Chairman; board member)inTom O'Brien(Co-founder; SVP Sales (2013–2018))Ben Matlin(Chief Executive Officer)Nat Brogadir(President)

BoardPeter Thiel(Director)inJoe Lonsdale(Director)in

Co-investorsAshton KutcherAtomicBain Capital VenturesFelicis VenturesFirst Round CapitalKevin Durant+6 more

City Blockcityblock.comin𝕏Dec 2017

Cityblock provides primary care and health services focused on making healthcare accessible as a basic right, particularly serving underserved and marginalized communities with an emphasis on trust-based, inclusive care.

Digital HealthHealthtechImpact & Social GoodMental HealthBrooklyn, US

Iyah Romm(Founder)Toyin Ajayi(Founder)inMat Balez(Founder)inSusan Brown(Executive Officer)Bay Gross(Founder)

BoardAndy Slavitt(Director)in

Co-investors8VCEcho Health VenturesGeneral CatalystKinnevikLifeforce CapitalNat Turner+11 more

Cyleracylera.comin𝕏Jul 2017 · $10M

Cylera provides a healthcare cybersecurity platform focused on connected medical devices, IoT, and IT assets, giving hospitals and health systems visibility, risk assessment, and threat detection across their environments.

CybersecurityHealthtechIoTNew York, US

Timur Ozekcin(Executive Officer, Director)inSean Abraham(Executive Officer, Director)inApostolos Bakoyiannis(Executive Officer)Owen Wilson(Director)

Co-investorsAlumni VenturesContour Venture PartnersDreamit VenturesEpsilon Health InvestorsFrontier Path VCGaingels+8 more

Devoted Healthdevoted.comOct 2017

Devoted Health offers Medicare Advantage plans and integrated healthcare services for older Americans, including virtual and in-home care, member support guides, and coordination with local providers across 29 states.

HealthtechInsurTechUnited States, US

Todd Park(Founder)inEd Park(Founder)in

BoardBryan Roberts(Director)inRobert Kocher(Director)inWilliam Frist(Director)inKathleen Sebelius(Director)

Co-investorsAndreessen HorowitzBronze InvestmentsCapital FactoryCox EnterprisesDns CapitalDreamers VC+31 more

Etleapetleap.comin𝕏Seed · Jun 2017

Etleap provides a pipeline platform built around Apache Iceberg that handles data ingestion, transformation, and operation for enterprise analytics.

Data & InfrastructureEnterprise SoftwareSaaSSan Francisco, US

Christian Romming(CEO)inAlexi RobichauxAshley Scannell(Operations Manager)Michael Rosenberg(Recruiter)Matt Korus(Customer Experience Manager)Francis Vu(Operations Manager)

Co-investorsFirst Round CapitalY CombinatorAndreessen HorowitzBoxGroupGeneral CatalystLiquid Ventures+4 more

Homology Medicineshomologymedicines.cominJul 2017

Clinical-stage genetic medicines company using human-derived AAV vectors and nuclease-free gene editing for rare diseases.

BiotechBedford, US

Siyamak Rasty(Executive Officer)Albert Seymour(Executive Officer)

BoardSteven Gillis(Director)Arthur Tzianabos(Executive Officer, Director)Kush Parmar(Director)inRichard Gregory(Director)

Co-investors5AM VenturesARCH Venture PartnersOUP (Osage University Partners)AlexandriaDeerfield Management CompanyFidelity Investments+5 more

Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.